Idelalisib D5
- CAS NO.：1830330-31-8
- Empirical Formula: C22H18FN7O
- Molecular Weight: 415.43
- MDL number: MFCD34469853
- Update Date: 2026-04-21 10:31:43
What is Idelalisib D5?
Biological Activity
Idelalisib D5 is a deuterium labeled Idelalisib. Idelalisib is a highly selective and orally bioavailable p110δ inhibitor[1].
References
[1]. Lannutti BJ, et al. CAL-101, a p110delta selective phosphatidylinositol-3-kinase inhibitor for the treatment of B-cell malignancies, inhibits PI3K signaling and cellular viability. Blood, 2011, 117(2), 591-594.
Properties of Idelalisib D5
| storage temp. | Store at -20°C |
| form | Solid |
| color | White to off-white |
Safety information for Idelalisib D5
Computed Descriptors for Idelalisib D5
New Products
3-AMINO-3-(2-CHLORO-PHENYL)-PROPIONIC ACID 4-Fluorophenylglycine 1-Boc-3-(cyanomethyl)azetidine Dimedone 1-N-Boc-3-(aminoethyl)azetidine N-BOC-piperidine-4-carboxylic acid 4,6-Dichlororesorcinol 5-Amino-2-Bromo-3-Chloropyridine 2-Picolinic acid N-oxide 4-Butyl Resorcinol 2-Bromo-5-Chloropyridine 5-Bromo-2-Hydroxy-3-Nitro Pyridine 2-Amino-4-phenyl-thiazole N-(4-Bromophenyl)-2-chloroacetamide TRIFLOURO ACETICACID-D METHANE SULFONIC ACID-D4 PHOSPORIC ACID-D3 85 W% IN D2O DEUTERIUM OXIDE FOR NMR BENZENE-D6 TOLUENE-D3You may like
-
IODOETHANE-D5 6485-58-1 99%View Details
6485-58-1 -
32008-59-6 PARAFORMALDEHYDE-D2 98%View Details
32008-59-6 -
CHLORO BENZENE-D5 3114-55-4 99%View Details
3114-55-4 -
PHENYL ACETYLENE-D 3240-11-07 99%View Details
3240-11-07 -
918-20-7 TERT-BUTYL CHLORIDE-D9 98%View Details
918-20-7 -
84358-13-4 N-BOC-piperidine-4-carboxylic acid 98+View Details
84358-13-4 -
84358-13-4 N-BOC-piperidine-4-carboxylic acid 98+View Details
84358-13-4 -
84358-13-4 N-BOC-piperidine-4-carboxylic acid 98+View Details
84358-13-4
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.